The SPDR® S&P® International Health Care Sector ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Developed Ex-U.S. BMI Health Care Sector Index.
Ordinary brokerage commissions may apply.
|Primary Benchmark||S&P Developed Ex-U.S. BMI Health Care Sector Index|
|Short Selling Allowed||Yes|
|Gross Expense Ratio||0.50%|
|Investment Manager||SSgA Funds Management, Inc.|
|Management Team||ETF Management Team - Non US|
|Distributor||State Street Global Markets, LLC|
|Exchange||NYSE ARCA EXCHANGE|
|Est. 3-5 Year EPS Growth||9.26%|
|FY 1 P/E Ratio||16.80|
|Number of Holdings||118|
|Weighted Average Market Cap||$88,413.02 M|
|30 Day SEC Yield||1.85%|
|Est. 3-5 Year EPS Growth||9.80%|
|FY 1 P/E Ratio||16.85|
|Number of Holdings||309|
|Return On Equity||23.62%|
|Exchange Volume (shares)||4,683|
|Shares Outstanding||1.25 M|
|Total Net Assets||$56.21 M|
|Weighted Average Market Cap||$82,851.59 M|
Buying and Selling ETFs
ETFs are flexible and easy to trade. Investors buy and sell them like stocks, typically through a brokerage account. Investors can also employ traditional stock trading techniques; including stop orders, limit orders, margin purchases, and short sales using ETFs. They are listed on major US Stock Exchanges.
ETFs are subject to risk similar to those of stocks including those regarding short-selling and margin account maintenance.
Ordinary brokerage commissions apply.
Month End as of 03/31/2014
Fund Inception Date: 07/16/2008
Index Inception Date: 07/16/2008
Quarter End as of 03/31/2014
Fund Inception Date: 07/16/2008
Index Inception Date: 07/16/2008
|Roche Holding Ltd Genusssch.||8.80%||17,105|
|Novo Nordisk A/S Class B||5.06%||66,319|
|Teva Pharmaceutical Industries Limited||3.36%||37,362|
|Roche Holding AG||2.88%||5,625|
|Valeant Pharmaceuticals International Inc.||2.63%||12,286|
|Roche Holding Ltd Genusssch.||10.45%|
|Novo Nordisk A/S Class B||4.80%|
|Teva Pharmaceutical Industries Limited||3.68%|
|Valeant Pharmaceuticals International Inc.||2.75%|
|Takeda Pharmaceutical Co. Ltd.||2.39%|
Subject to change.
After-tax returns are calculated based on NAV using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.
Performance of an index is not illustrative of any particular investment. It is not possible to invest directly in an index.
The historical values for this index were calculated based on the current S&P Global BMI Equity methodology, the parent index of the S&P Developed Ex-U.S. BMI Sector Capped Indices, using historical component-level data. The historical values were designed to reflect the performance of what would have been the actual components of the Index at the time. Securities meeting the required criteria for inclusion according to the methodology were included; no discretion was employed in the selection outside of applying the criteria. To create the history for the S&P Developed Ex-U.S. BMI Sector Capped Index the following methodology was used:
Index Eligibility: To be eligible for the S&P Developed Ex-U.S. BMI Sector Capped index, companies must first be constituents of the S&P Global BMI Equity index.Eligibility Factors:Market Capitalization. Stocks must have a float-adjusted market capitalization above US$100 million.Liquidity. Stocks must have 12-month average total daily value traded above US$50 million.Domicile . All constituents are members of the developed markets, as defined by the S&PGlobal BMI Equity methodology excluding the United States.Sector Classification. Stocks are classified by the Global Industry Classification Standard (GICS®) – a four-tiered industry classification structure. The indices provide geographic and economic balance across the 10 GICS Sectors. These Sectors, consistent across all Standard & Poor ’ s indices, are Consumer Discretionary, Consumer Staples, Energy, Financials, Health Care, Industrials, Information Technology, Materials, Telecommunication Services, and Utilities.
Timing of Changes. The index is reviewed quarterly to adjust the index weights if necessary. Quarterly rebalancings will take place on the third Friday of each March, June and December. The September rebalancing will be on September 30 to coincide with the annual reconstitution of the index, effective for October 1. The cut-off date for the data used in the annual reconstitution is the last business day of the prior July. New constituents and index weights will be made available to clients with a five-day notice.Additions. Companies may be added between rebalancings periods due to sector re- classifications, listing of eligible IPOs, and eligible spin-offs.Deletions. Between rebalancings, a company can be deleted from one the ten S&P Developed Ex-U.S. BMI Sector Capped Indices due to corporate events such as mergers, acquisitions, takeovers, delistings, or sector reclassification.
Index Construction: 1. All constituents of the S&P Developed Ex-U.S. BMI Sector Capped index must first be constituents of the S&P Global BMI Equity index. These constituents already meet the size and liquidity criteria. This becomes the initial selection universe. 2. All securities of the United States and constituents of emerging markets, as defined by the S&P Global BMI Equity methodology are removed from the list. 3. Companies are then sorted by sector classification and by float market cap within each sector. 4. The remaining stocks are sorted in decreasing order of their float-adjusted market capitalization within each of its corresponding sector. Each sector then becomes an individual index.5. Index weights are calculated for each of the constituents in each of the sectors. In each of the sector indices, no stock can exceeds 20% of the index; stocks that exceed 5% of the index market cap weight, in aggregate, should not exceed 45% of the index. In order to maintain these thresholds, the market capitalization may be modified to comply with these guidelines. Please note that back-tested performance does not represent actual performance and should not be interpreted as an indication of actual performance. Back-tested index performance is for informational purposes only. Index performance returns do not reflect management fees, transaction costs or expenses that may be associated with a fund that seeks to replicate the performance of an index. Indexes are unmanaged and one cannot invest directly in an index.
As with all stocks, you may be required to deposit more money or securities into your margin account if the equity, including the amount attributable to your ETF shares, declines.
Unless otherwise noted all information contained herein is that of the SPDR S&P International Health Care Sector ETF.
The Fund invests by sampling the index, holding a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. This may cause the fund to experience tracking errors relative to performance of the index.
S&P - In net total return indices, the dividends are reinvested after the deduction of withholding tax. Tax rates are applied at the country level or at the index level.